Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind study of ozenoxacin 1% cream versus placebo in patients with impetigo
2014-000228-52Phase 3Completed
- Sponsor
- Ferrer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in impetigo comparing Ozenoxacin 1% cream with Placebo cream (2 arms). Started Apr 2014; status: completed.
02
Drugs
ozenoxacin
03
Conditions
impetigo
Beyond the preview
Go deeper on 2014-000228-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000228-52.